Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Long-Term Extension Study to Assess the Safety and Efficacy of Lu AA21004 in Patients With Major Depressive Disorder (Extension to Lu AA21004/CCT-003 Study)

NCT01395147 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01395147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01395147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Long-Term Extension Study to Assess the Safety and Efficacy of Lu AA21004 in Patients With Major Depressive Disorder (Extension to Lu AA21004/CCT-003 Study)
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
May 31, 2013
Enrollment
119 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder